Unlike blocking tumor progression or invasion signals in part, CD40 agonism is an “ignition” signal resulting in APC activation, macrophage tumoricidal activity, and CD8+ T cell-dependent antitumor immunity. The gene discussed is CD8A; the disease is neoplasm.